A deep dive masterclass on sovereign debt restructuring, to be conducted virtually by Asian high yield bond expert Florian Schmidt.

30 June 2022 (Thu), 5pm Singapore/HK time

Jubilant Pharma Upgraded to BB by S&P Following Fitch

Jubilant Pharma Upgraded to BB by Fitch

The credit rating of India’s Jubilant Pharma Limited (JPL) has been upgraded to BB from BB- by Fitch on the back of improvements in its business profile. The rating action comes as the Life Science Ingredient (LSI) business of its parent Jubilant Pharmova Ltd...
Show Buttons
Hide Buttons